GE invests in noninvasive glucose monitoring firm C8 MediSensors; loans $10m to InfraReDx
This article was originally published in Clinica
Executive Summary
GE Healthcare has invested some of its healthymagination fund in privately-held noninvasive glucose monitoring developer C8 MediSensors. The amount invested was not disclosed; however, it made up a "significant" part of a $24m preferred C stock financing, C8 said.